Jellert Gaublomme

Assistant Professor

Columbia University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

Missense mutations in PTPN11 , which encodes the protein tyrosine phosphatase SHP2, are common in several developmental disorders and cancers. While many mutations disrupt auto-inhibition and hyperactivate SHP2, several do not enhance catalytic activity. Both activating and non-activating mutations could potentially drive pathogenic signaling by altering SHP2 interactions or localization. We employed proximity-labeling proteomics to map the interaction networks of wild-type SHP2, ten clinically relevant mutants, and SHP2 bound to an inhibitor that stabilizes its auto-inhibited state. Our analyses reveal mutation- and inhibitor-dependent alterations in the SHP2 interactome, with several mutations also changing localization. Some mutants show increased mitochondrial localization and impact mitochondrial function. This study provides a resource for exploring SHP2 signaling and offers new insights into the molecular basis of SHP2-driven diseases. Furthermore, this work highlights the capacity for proximity-labeling proteomics to detect missense-mutation-dependent changes in protein interactions and localization.

Year:

2025

Missense mutations in PTPN11 , which encodes the protein tyrosine phosphatase SHP2, are common in several developmental disorders and cancers. While many mutations disrupt auto-inhibition and hyperactivate SHP2, several do not enhance catalytic activity. Both activating and non-activating mutations could potentially drive pathogenic signaling by altering SHP2 interactions or localization. We employed proximity-labeling proteomics to map the interaction networks of wild-type SHP2, ten clinically-relevant mutants, and SHP2 bound to an inhibitor that stabilizes its auto-inhibited state. Our analyses revealed mutation- and inhibitor-dependent alterations in the SHP2 interactome, with several mutations also changing localization. Some mutants had increased mitochondrial localization and impacted mitochondrial function. This study provides a resource for exploring SHP2 signaling and offers new insights into the molecular basis of SHP2-driven diseases. Furthermore, this work highlights the capacity for proximity-labeling proteomics to detect missense-mutation-dependent changes in protein interactions and localization.

Year:

2025

Year:

2023

Collaborators (9)

Rashmi Voleti

Columbia University

UNITED STATES
View details

Semir Beyaz

Principal Investigator

Cold Spring Harbor Laboratory

UNITED STATES
View details

Lori Coburn

Associate Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Alison Simmons

Director

University of Oxford

UNITED KINGDOM
View details

Ziyuan Jiang

Weill Cornell Medicine

UNITED STATES
View details

Jose Ordovas-Montanes

Research Faculty

Boston Children's Hospital

UNITED STATES
View details

Neel H Shah

Associate Professor

Columbia University

UNITED STATES
View details

Kylie Renee James

University of New South Wales

AUSTRALIA
View details

Marko Jovanovic

Columbia University

UNITED STATES
View details